https://pipelinereview.com/Eloxx-Pharmaceuticals-Presents-Positive-New-Data-for-Lead-Investigational-Drug-ELX-02-at-the-42nd-European-Cystic-Fibrosis-Society-Conference-ECFS/
Eloxx Pharmaceuticals Presents Positive New Data for Lead Investigational Drug, ELX-02, at the 42nd European Cystic Fibrosis Society Conference (ECFS)